Facilitated By

San Antonio Medical Foundation

CV19: vaccine development

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Klose, Karl
Funded by
Texas Biomedical Research Institute
Research Start Date
Status
Inactive

Basic Research

Collaborative Project
Basic Research
Infectious Disease